Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03931512
Other study ID # R-0022/18
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 30, 2019
Est. completion date June 1, 2019

Study information

Verified date June 2022
Source Centro Universitario La Salle
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Clinical Trial with two groups, transcranial direct current stimulation aplication and sham; triple blinded. The protocol is applied 5 consecutive days during the training of a manual dexterity task. Manual dexterity and somatosensory variables are measured pre intervention, post one day of intervention, post 5 days of intervention, and 5 days after finish the intervention.


Description:

Clinical Trial with two groups, transcranial direct current stimulation aplication (1 mA ) and sham (ramp up and down of 30 seconds in total) . Bouth interventions will last 20 minutes; at the same time of the aplication bouth are going to train the manual dexterity with Purdue Pegboard Test. This protocol is applied 5 consecutive days, also it have a follow up of 5 days more. It is triple blinded. Manual dexterity and somatosensory variables are measured pre intervention, post one day of intervention, post 5 days of intervention, and 5 days after finish the intervention.


Recruitment information / eligibility

Status Completed
Enrollment 33
Est. completion date June 1, 2019
Est. primary completion date June 1, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - healthy volunteers Exclusion Criteria: - metal or skin lesions on the head - brain stimulation in the last 6 months - family history of epilepsy or seizures - pacemaker or any cardiac involvement - inability to understand or execute the task - taking drugs that may influence cognition - pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Device:
transcranial direct current stimularion
aplication of direct current stimulation on the scalp wiht sponge electrodes

Locations

Country Name City State
Spain CEULaSalle Madrid

Sponsors (1)

Lead Sponsor Collaborator
Centro Universitario La Salle

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in trained manual dexterity of the dominant hand One hand manual dexterity is measured with Perdue Pegboard test pre intervention, post one day of intervention, post 5 days of intervention, 5 days after finish the intervention
Secondary Changes in trained manual dexterity of bouth hands Two hands dexterity is measured with Perdue Pegboard test pre intervention, post one day of intervention, post 5 days of intervention, 5 days after finish the intervention
Secondary Changes in maximal isometric hand grip force Hand grip force is measured with Jamar dinamometer pre intervention, post one day of intervention, post 5 days of intervention, 5 days after finish the intervention
Secondary Sleep Quality Pittsburgh Sleep Quality Index 5 days after finish the intervention
Secondary Physical activity Long form of the International Physical Activity Questionnaire 5 days after finish the intervention
Secondary Changes in nontrained manual dexterity of the dominant hand One hand dexterity is mesured with Minesota Test pre intervention, post one day of intervention, post 5 days of intervention, 5 days after finish the intervention
Secondary Changes in nontrained manual dexterity of bouth hands Two hands dexterity is mesured with Minesota Test pre intervention, post one day of intervention, post 5 days of intervention, 5 days after finish the intervention
Secondary Changes in pressure detection treshold The pressure detection treshold is measured with an algometer pre intervention, post one day of intervention, post 5 days of intervention, 5 days after finish the intervention
Secondary Changes in pain detection treshold The pain detection treshold is measured with an algometer pre intervention, post one day of intervention, post 5 days of intervention, 5 days after finish the intervention
Secondary Changes in two points discrimination Two points discrimination is measured with an esthesiometer pre intervention, post one day of intervention, post 5 days of intervention, 5 days after finish the intervention
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1